- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Durata Therapeutics Inc+ Add to Watchlist
DRTX:US14.1500 USD 0.0300 0.21%
As of 20:10:00 ET on 03/07/2014.
Company Profile for Durata Therapeutics Inc (DRTX)
Durata Therapeutics, Inc. develops, acquires, and commercializes therapeutics for the treatment of infectious diseases. The Company focuses on antibiotic treatments for acute bacterial skin and skin structure infections for the specialist physician market.
Durata Therapeutics Inc
Key Executives for Durata Therapeutics Inc (DRTX)
|Paul R EdickChief Executive Officer||Corey N FishmanCFO/COO/Treasurer/Secretary|
|John P ShannonChief Commercial Officer||Michael DunneChief Medical Officer|
|Allison WeyVP:Investor Relations & Public|